Open-label Extension to Protocol 1042-0500
Public ClinicalTrials.gov record NCT00442104. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Clinical Study to Evaluate the Safety and Antiepileptic Activity of Ganaxolone in Treatment of Patients Diagnosed With Infantile Spasms.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To allow open-label extension to patients who have completed Protocol 1042-0500
Study identification
- NCT ID
- NCT00442104
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 4 Months to 24 Months
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2007 (Actual)
- Primary completion
- Mar 2009 (Actual)
- Completion
- Mar 2009 (Actual)
- Last update posted
- May 28, 2024
2007 – 2009
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hospital of Los Angeles | Los Angeles | California | 90027 | — |
| Mattel Children's Hospital at UCLA | Los Angeles | California | 90095 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| Miami Children's Hospital, The Brain Institute | Miami | Florida | 33155 | — |
| Child Neurology Center of Nrothwest Florida, P.A. | Pensacola | Florida | 32504 | — |
| University of Chicago Comer Children's Hospital | Chicago | Illinois | 60637 | — |
| Minnesota Epilepsy Group, P.A. | Saint Paul | Minnesota | 55102 | — |
| Montefiore Medical Center- Albert Einstein College of Medicine | The Bronx | New York | 10467 | — |
| Le Bonheur Children's Medical Center | Memphis | Tennessee | 38105 | — |
| Dallas Pediatric Neurology Associates | Dallas | Texas | 75230 | — |
| Texas Children's Hospital | Houston | Texas | 77030 | — |
| Virginia Commonwealth University Health Systems | Richmond | Virginia | 23298 | — |
| Children's Hospital and Regional Medical Center | Seattle | Washington | 98105 | — |
| Children's Hospital of Wisconsin | Milwaukee | Wisconsin | 53201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00442104, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 28, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00442104 live on ClinicalTrials.gov.